330 related articles for article (PubMed ID: 37688519)
1. Molecular and environmental contributors to neurological complications in sickle cell disease.
Karkoska KA; Gollamudi J; Hyacinth HI
Exp Biol Med (Maywood); 2023 Aug; 248(15):1319-1332. PubMed ID: 37688519
[TBL] [Abstract][Full Text] [Related]
2. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
[TBL] [Abstract][Full Text] [Related]
3. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
[TBL] [Abstract][Full Text] [Related]
4. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
[TBL] [Abstract][Full Text] [Related]
5. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003146. PubMed ID: 28094851
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin PM; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
[TBL] [Abstract][Full Text] [Related]
7. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Wang WC; Dwan K
Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
[TBL] [Abstract][Full Text] [Related]
8. Stroke in sickle cell disease and the promise of recent disease modifying agents.
Runge A; Brazel D; Pakbaz Z
J Neurol Sci; 2022 Nov; 442():120412. PubMed ID: 36150233
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea can be used in children with sickle cell disease and cerebral vasculopathy for the prevention of chronic complications? A meta-analysis.
Núñez RM; Figueroa CAP; García-Perdomo HA
J Child Health Care; 2020 Mar; 24(1):64-77. PubMed ID: 30606035
[TBL] [Abstract][Full Text] [Related]
10. Sickle Cell Disease: A Review.
Kavanagh PL; Fasipe TA; Wun T
JAMA; 2022 Jul; 328(1):57-68. PubMed ID: 35788790
[TBL] [Abstract][Full Text] [Related]
11. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Rankine-Mullings AE; Nevitt SJ
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Nevitt SJ; Jones AP; Howard J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
[TBL] [Abstract][Full Text] [Related]
14. Preoperative blood transfusions for sickle cell disease.
Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.
Dexter D; McGann PT
Pharmacotherapy; 2023 May; 43(5):430-441. PubMed ID: 36906823
[TBL] [Abstract][Full Text] [Related]
16. Disease-Modifying Therapies for Sickle Cell Disease-An Overview.
Peddinti R
Pediatr Ann; 2024 Feb; 53(2):e52-e55. PubMed ID: 38302121
[TBL] [Abstract][Full Text] [Related]
17. Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
Russo G; De Franceschi L; Colombatti R; Rigano P; Perrotta S; Voi V; Palazzi G; Fidone C; Quota A; Graziadei G; Pietrangelo A; Pinto V; Ruffo GB; Sorrentino F; Venturelli D; Casale M; Ferrara F; Sainati L; Cappellini MD; Piga A; Maggio A; Forni GL
Orphanet J Rare Dis; 2019 May; 14(1):120. PubMed ID: 31146777
[TBL] [Abstract][Full Text] [Related]
18. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
19. Sickle Cell Disease and Stroke.
Hirtz D; Kirkham FJ
Pediatr Neurol; 2019 Jun; 95():34-41. PubMed ID: 30948147
[TBL] [Abstract][Full Text] [Related]
20. Blood transfusion for preventing stroke in people with sickle cell disease.
Riddington C; Wang W
Cochrane Database Syst Rev; 2002; (1):CD003146. PubMed ID: 11869654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]